Cargando…
Indoleacrylic acid produced by Parabacteroides distasonis alleviates type 2 diabetes via activation of AhR to repair intestinal barrier
BACKGROUND: Anti-inflammatory therapy is an effective strategy in the treatment of type 2 diabetes (T2D). Studies found that inflammatory responses in vivo were strongly associated with defects in the mucosal barrier function of the gut epithelium. While some microbial strains could help repair the...
Autores principales: | Liu, Deliang, Zhang, Shaobao, Li, Siju, Zhang, Qian, Cai, Ying, Li, Pei, Li, Hao, Shen, Baochun, Liao, Qiongfeng, Hong, Yanjun, Xie, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114473/ https://www.ncbi.nlm.nih.gov/pubmed/37072819 http://dx.doi.org/10.1186/s12915-023-01578-2 |
Ejemplares similares
-
Parabacteroides distasonis Properties Linked to the Selection of New Biotherapeutics
por: Chamarande, Jordan, et al.
Publicado: (2022) -
Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a
por: Sun, Yonggan, et al.
Publicado: (2023) -
Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity
por: Cuffaro, Bernardo, et al.
Publicado: (2023) -
Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid
por: Wei, Wenchao, et al.
Publicado: (2023) -
In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Parabacteroides distasonis Strains Alleviating TNBS-Induced Colitis in Mice
por: Cuffaro, Bernardo, et al.
Publicado: (2020)